vimarsana.com
Home
Live Updates
GSK to buy asthma drug developer for up to $1.4 billion in pipeline push : comparemela.com
GSK to buy asthma drug developer for up to $1.4 billion in pipeline push
The British pharmaceutical giant's deal will give it access to Aiolos' AIO-001 asthma treatment
Related Keywords
San Francisco ,
California ,
United States ,
China ,
United Kingdom ,
Chinese ,
British ,
Bristol Myers Squibb ,
Aiolos Bio ,
Luke Miels ,
Bain Capital Life Sciences ,
Jiangsu Pharmaceutical Co ,
Bellus Health ,
Aiolo Phase ,
Bain Capital Life ,
Karuna Therapeutics ,
Wall Street Journal ,
Sunday Times ,
Elliott Management ,
Chongqing Zhifei Biological Products ,
Article Normal ,
Biotechnology Services ,
Pharmaceuticals ,
Respiratory Allergy Treatments ,
Healthcare Life Sciences ,
Aerospace Defense ,
Defense Equipment Products ,
Specialized Drugs Medications ,
Industrial Goods ,
Ownership Changes ,
Acquisitions Mergers Shareholdings ,
Acquisitions Mergers ,
Corporate Actions ,
Corporate Industrial News ,
Asthma ,
Political General News ,
Respiratory Tract Diseases ,
Health ,
Medical Conditions ,
Content Types ,
Factiva Filters ,
C Amp Ampe Industry News Filter ,
Gsk Plc ,
Uk Gsk ,
Bristol Myers Squibb Co ,
Bmy ,
Abbvie Inc ,
Abbv ,
Acquisitions ,
Mergers ,
Shareholdings ,
Corporate ,
Industrial News ,
Political ,
General News ,
Respiratory ,
Allergy Treatments ,
Healthcare ,
Life Sciences ,
Aerospace ,
Defense ,
Defense Equipment ,
Products ,
Specialized Drugs ,
Medications ,
comparemela.com © 2020. All Rights Reserved.